Dynamic quotes: Off
|
Company Description (as filed with the SEC)
To become a recognized leader in the advancement of women’s health by providing innovative methods to detect, monitor and manage the treatment of gynecologic cancers and other related diseases Corporate Mission: We will develop and commercialize high-value multi-marker diagnostic tests which address unmet needs in gynecologic oncology and women’s health. We will accomplish our mission through internal development, targeted acquisitions, and collaborations with leading scientific and clinical institutions. Our commercial efforts will include direct marketing and sales activities as well as partnerships with leading companies in women’s health. Mission Statement: We are dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. ... More ...
Analyst Info |
|
| Annual EPS Est: | $-0.53 |
| Quarterly EPS Est: | -0.15 |
| PEG Ratio: | .00 |
|
Mean Recommendation: View Summary / View All |
3 |
Data is provided by Zacks Investment Research
